financetom
Business
financetom
/
Business
/
Ad firm Interpublic beats quarterly estimates on resilient client spending
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ad firm Interpublic beats quarterly estimates on resilient client spending
Jul 22, 2025 6:55 AM

(Reuters) -Ad group Interpublic surpassed analysts' estimates for second-quarter revenue and profit on Tuesday, thanks to resilient marketing spend from clients, sending its shares up nearly 5%.

The results are the latest sign that ad spending is holding firm in an uncertain economy, after French ad giant Publicis and Omnicom also reported upbeat earnings. Increasing use of AI for creating ads has sparked worries about the industry that has long been the creative voice for brands.

Interpublic benefited in the April-June quarter from strong spending from its media and healthcare-focused businesses, as well as growth in its sports marketing and public relations units, CEO Philippe Krakowsky said.

The company, which last year signed a $13.25 billion merger with Omnicom to create the world's largest ad agency and better navigate the changing industry landscape, also said it expects the deal to close in the second half of the year.

Interpublic's media services are managed through IPG Mediabrands, which includes brands such as Initiative and Mediahub. Its healthcare marketing is managed under the unified IPG Health network.

The company reported second-quarter revenue of $2.54 billion, compared with analysts' average estimate of $2.17 billion, according to data compiled by LSEG.

Its adjusted profit per share of 75 cents also beat the estimate of 56 cents.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved